TNFRSF11A and Miyoshi myopathy: Finally we demonstrated that increasing doses of anti-LIGHT (Abs) or RANK-Fc induced a dose-dependent reduction of OC numbers in PBMCs from MM patients with active bone disease in responders, at relapse and PD (Figure 5), supporting the involvement of LIGHT and RANKL in the spontaneous osteoclastogenesis.